RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
WuXi Biologics (Cayman) Stock

WuXi Biologics (Cayman) Equity 2024

WuXi Biologics (Cayman) Equity

40.33 B CNY

Ticker

2269.HK

ISIN

KYG970081173

WKN

A2QJCN

In 2024, WuXi Biologics (Cayman)'s equity was 40.33 B CNY, a 15.08% increase from the 35.05 B CNY equity in the previous year.

WuXi Biologics (Cayman) Aktienanalyse

What does WuXi Biologics (Cayman) do?

WuXi Biologics (Cayman) Inc. is a company specializing in the development and manufacturing of biopharmaceuticals. It was founded in 2015 and is headquartered in Shanghai, China. WuXi Biologics is the world's largest biologics development and manufacturing services company and is also listed on the Hong Kong Stock Exchange. WuXi Biologics (Cayman) ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing WuXi Biologics (Cayman)'s Equity

WuXi Biologics (Cayman)'s equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding WuXi Biologics (Cayman)'s equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating WuXi Biologics (Cayman)'s equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

WuXi Biologics (Cayman)'s equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in WuXi Biologics (Cayman)’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about WuXi Biologics (Cayman) stock

What is the equity of WuXi Biologics (Cayman) this year?

WuXi Biologics (Cayman) has equity of 40.33 B CNY this year.

What was the equity of WuXi Biologics (Cayman) compared to the previous year?

The equity of WuXi Biologics (Cayman) has increased/decreased by 15.08% increased compared to the previous year.

What impact does a high equity have on investors of WuXi Biologics (Cayman)?

A high equity is advantageous for investors of WuXi Biologics (Cayman) as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of WuXi Biologics (Cayman)?

A low equity can be a risk for investors of WuXi Biologics (Cayman), as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of WuXi Biologics (Cayman) affect the company?

An increase in equity of WuXi Biologics (Cayman) can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of WuXi Biologics (Cayman) affect the company?

A reduction in equity of WuXi Biologics (Cayman) can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of WuXi Biologics (Cayman)?

Some factors that can affect the equity of WuXi Biologics (Cayman) include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of WuXi Biologics (Cayman) so important for investors?

The equity of WuXi Biologics (Cayman) is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can WuXi Biologics (Cayman) take to change the equity?

To change equity, WuXi Biologics (Cayman) can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does WuXi Biologics (Cayman) pay?

Over the past 12 months, WuXi Biologics (Cayman) paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, WuXi Biologics (Cayman) is expected to pay a dividend of 0 CNY.

What is the dividend yield of WuXi Biologics (Cayman)?

The current dividend yield of WuXi Biologics (Cayman) is .

When does WuXi Biologics (Cayman) pay dividends?

WuXi Biologics (Cayman) pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of WuXi Biologics (Cayman)?

WuXi Biologics (Cayman) paid dividends every year for the past 0 years.

What is the dividend of WuXi Biologics (Cayman)?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is WuXi Biologics (Cayman) located?

WuXi Biologics (Cayman) is assigned to the 'Health' sector.

Wann musste ich die Aktien von WuXi Biologics (Cayman) kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of WuXi Biologics (Cayman) from 11/20/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 11/20/2024.

When did WuXi Biologics (Cayman) pay the last dividend?

The last dividend was paid out on 11/20/2024.

What was the dividend of WuXi Biologics (Cayman) in the year 2023?

In the year 2023, WuXi Biologics (Cayman) distributed 0 CNY as dividends.

In which currency does WuXi Biologics (Cayman) pay out the dividend?

The dividends of WuXi Biologics (Cayman) are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von WuXi Biologics (Cayman)

Our stock analysis for WuXi Biologics (Cayman) Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of WuXi Biologics (Cayman) Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.